Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Ping Fan

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 27, 2012
[The outcome and safety of mesenchymal stem cells from bone marrow of a third party donor in treatment of secondary poor graft function following allogeneic hematopoietic stem cell transplantation]Xiao-Dan Liu, Zhi-Ping Fan, Yan-Wen Peng, et al.
Zhonghua Yi Xue Za Zhi|July 16, 2011
[Allogeneic hematopoietic stem cell transplantation for acute leukemias of ambiguous lineage in adults: a comparison between the conditioning of different intensities]Yu Zhang, Yin-kui Chen, Qi-fa Liu, et al.
American Journal of Cancer Research|May 5, 2021
Allogeneic hematopoietic stem cell transplantation overcomes the poor prognosis in MLL-rearranged solid tumor therapy related-acute myeloid leukemiaHan-Zhou Qi, Na Xu, Jun Xu, et al.
Cancer Medicine|October 20, 2021
Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single-center retrospective studyWei-Ran Lv, Ya Zhou, Jun Xu, et al.
Blood Cells, Molecules & Diseases|January 8, 2011
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesisXiao-dan Luo, Qi-fa Liu, Yu Zhang, et al.
Clinical Transplantation|April 21, 2012
Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center studyYu Wang, Dai-Hong Liu, Zhi-Ping Fan, et al.
Cell Death & Disease|March 24, 2021
Wnt/β-catenin signaling mediates the abnormal osteogenic and adipogenic capabilities of bone marrow mesenchymal stem cells from chronic graft-versus-host disease patientsHan-Zhou Qi, Yi-Ling Ye, Yuan Suo, et al.
International Journal of Cancer|December 1, 2019
Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCTJia-Bao He, Xin Zhang, Zi-Wen Guo, et al.
Annals of Hematology|January 1, 2013
Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimensQi-Fa Liu, Zhi-Ping Fan, Mei-Qing Wu, et al.
British Journal of Haematology|July 25, 2017
Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remissionLi-Jie Han, Yu Wang, Zhi-Ping Fan, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 27, 2012
[The outcome and safety of mesenchymal stem cells from bone marrow of a third party donor in treatment of secondary poor graft function following allogeneic hematopoietic stem cell transplantation]Xiao-Dan Liu, Zhi-Ping Fan, Yan-Wen Peng, et al.
Zhonghua Yi Xue Za Zhi|July 16, 2011
[Allogeneic hematopoietic stem cell transplantation for acute leukemias of ambiguous lineage in adults: a comparison between the conditioning of different intensities]Yu Zhang, Yin-kui Chen, Qi-fa Liu, et al.
American Journal of Cancer Research|May 5, 2021
Allogeneic hematopoietic stem cell transplantation overcomes the poor prognosis in MLL-rearranged solid tumor therapy related-acute myeloid leukemiaHan-Zhou Qi, Na Xu, Jun Xu, et al.
Cancer Medicine|October 20, 2021
Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single-center retrospective studyWei-Ran Lv, Ya Zhou, Jun Xu, et al.
Blood Cells, Molecules & Diseases|January 8, 2011
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesisXiao-dan Luo, Qi-fa Liu, Yu Zhang, et al.
Clinical Transplantation|April 21, 2012
Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center studyYu Wang, Dai-Hong Liu, Zhi-Ping Fan, et al.
Cell Death & Disease|March 24, 2021
Wnt/β-catenin signaling mediates the abnormal osteogenic and adipogenic capabilities of bone marrow mesenchymal stem cells from chronic graft-versus-host disease patientsHan-Zhou Qi, Yi-Ling Ye, Yuan Suo, et al.
International Journal of Cancer|December 1, 2019
Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCTJia-Bao He, Xin Zhang, Zi-Wen Guo, et al.
Annals of Hematology|January 1, 2013
Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimensQi-Fa Liu, Zhi-Ping Fan, Mei-Qing Wu, et al.
British Journal of Haematology|July 25, 2017
Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remissionLi-Jie Han, Yu Wang, Zhi-Ping Fan, et al.
Pageof 6